Literature DB >> 20133375

Protective and damaging effects of platelets in acute cholestatic liver injury revealed by depletion and inhibition strategies.

Bradley P Sullivan1, Ruipeng Wang, Ossama Tawfik, James P Luyendyk.   

Abstract

Alpha-naphthylisothiocyanate (ANIT) causes cholestatic hepatitis characterized by intrahepatic bile duct epithelial cell injury and periportal hepatocellular necrosis. The progression of ANIT-induced hepatocyte injury is reported to involve extrahepatic cells including platelets. We showed recently that the procoagulant protein tissue factor (TF) is essential for ANIT-induced coagulation and contributes to ANIT-induced liver necrosis. Platelets have been shown to express TF and can contribute to coagulation cascade activation. To this end, we tested the hypothesis that platelet-dependent coagulation contributes to ANIT-induced liver injury. In ANIT (60 mg/kg)-treated mice, activation of the coagulation cascade occurred prior to a decrease of platelets in the blood. Immunostaining for glycoprotein IIb (CD41) revealed platelet accumulation along the borders of necrotic foci in livers of ANIT-treated mice. Antibody-mediated platelet depletion did not affect coagulation but markedly affected liver histopathology in ANIT-treated mice. Platelet depletion induced marked pooling of blood within necrotic lesions consistent with parenchymal-type peliosis as early as 24 h after ANIT treatment. In contrast, treatment with the P2Y(12) inhibitor clopidogrel significantly reduced ANIT-induced hepatocyte necrosis and serum alanine aminotransferase activity but did not exaggerate bleeding into necrotic foci. Clopidogrel also reduced hepatic neutrophil accumulation but did not affect induction of Intercellular adhesion molecule-1 or chemokine CxC motif ligand-1 messenger RNA expression in liver. The data indicate that ANIT-induced coagulation is platelet independent and that platelets contribute to ANIT-induced hepatocyte necrosis by promoting neutrophil accumulation. In contrast, severe thrombocytopenia induces parenchymal-type peliosis in the livers of ANIT-treated mice, a rare hepatic lesion associated with pooling of blood in the liver.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133375      PMCID: PMC2855361          DOI: 10.1093/toxsci/kfq042

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  45 in total

Review 1.  Intrahepatic cholestasis induced by drugs and chemicals.

Authors:  G L Plaa; B G Priestly
Journal:  Pharmacol Rev       Date:  1976-09       Impact factor: 25.468

Review 2.  Peliosis hepatis in childhood: case report and review of the literature.

Authors:  M Samyn; N Hadzic; M Davenport; A Verma; J Karani; B Portmann; G Mieli-Vergani
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-10       Impact factor: 2.839

Review 3.  The blood platelet as a model for regulating blood coagulation on cell surfaces and its consequences.

Authors:  F A Ofosu
Journal:  Biochemistry (Mosc)       Date:  2002-01       Impact factor: 2.487

4.  Obstructive jaundice impairs hepatic sinusoidal endothelial cell function and renders liver susceptible to hepatic ischemia/reperfusion.

Authors:  H Yoshidome; M Miyazaki; H Shimizu; H Ito; K Nakagawa; S Ambiru; N Nakajima; M J Edwards; A B Lentsch
Journal:  J Hepatol       Date:  2000-07       Impact factor: 25.083

5.  Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis.

Authors:  S Russmann; A Zimmermann; S Krähenbühl; B Kern; J Reichen
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-03       Impact factor: 2.566

6.  The nature of alpha-naphthylisothiocyanate-induced cholestasis.

Authors:  B A Becker; G L Plaa
Journal:  Toxicol Appl Pharmacol       Date:  1965-09       Impact factor: 4.219

7.  ANIT toxicity toward mouse hepatocytes in vivo is mediated primarily by neutrophils via CD18.

Authors:  Pratima Kodali; Ping Wu; Parshawn A Lahiji; Eric J Brown; Jacquelyn J Maher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04-13       Impact factor: 4.052

8.  Endothelial cell injury and coagulation system activation during synergistic hepatotoxicity from monocrotaline and bacterial lipopolysaccharide coexposure.

Authors:  Steven B Yee; Umesh M Hanumegowda; Bryan L Copple; Masabumi Shibuya; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2003-05-02       Impact factor: 4.849

9.  Concanavalin-A-induced liver injury is severely impaired in mice deficient in P-selectin.

Authors:  Anna Massaguer; Sofía Perez-Del-Pulgar; Pablo Engel; Joan Serratosa; Jaime Bosch; Pilar Pizcueta
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

10.  Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice.

Authors:  Jaspreet S Gujral; Anwar Farhood; Mary Lynn Bajt; Hartmut Jaeschke
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

View more
  17 in total

1.  Platelets are relevant mediators of renal injury induced by primary endothelial lesions.

Authors:  Claudia Schwarzenberger; Jan Sradnick; Kenneth M Lerea; Michael S Goligorsky; Bernhard Nieswandt; Christian P M Hugo; Bernd Hohenstein
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-01

2.  Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury.

Authors:  James P Luyendyk; Nigel Mackman; Bradley P Sullivan
Journal:  Toxicol Sci       Date:  2010-10-25       Impact factor: 4.849

3.  Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice.

Authors:  Kazuhisa Miyakawa; Nikita Joshi; Bradley P Sullivan; Ryan Albee; Christina Brandenberger; Hartmut Jaeschke; Mitchell R McGill; Michael A Scott; Patricia E Ganey; James P Luyendyk; Robert A Roth
Journal:  Blood       Date:  2015-07-15       Impact factor: 22.113

4.  An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis.

Authors:  Zhen Shan; Shanshan Qin; Wen Li; Weibin Wu; Jian Yang; Maoping Chu; Xiaokun Li; Yuqing Huo; Gary L Schaer; Shenming Wang; Chunxiang Zhang
Journal:  J Am Coll Cardiol       Date:  2015-06-16       Impact factor: 24.094

5.  Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment.

Authors:  Patricia F Lalor; John Herbert; Roy Bicknell; David H Adams
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-20       Impact factor: 4.052

6.  Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.

Authors:  Nikita Joshi; Anna K Kopec; Jessica L Ray; James P Luyendyk
Journal:  Toxicology       Date:  2016-07-27       Impact factor: 4.221

7.  Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice.

Authors:  N Joshi; A K Kopec; K M O'Brien; K L Towery; H Cline-Fedewa; K J Williams; B L Copple; M J Flick; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2014-12-11       Impact factor: 5.824

Review 8.  Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association?

Authors:  Anna K Kopec; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2016-05-04       Impact factor: 4.180

Review 9.  Platelets as Modulators of Liver Diseases.

Authors:  Ton Lisman; James P Luyendyk
Journal:  Semin Thromb Hemost       Date:  2017-09-12       Impact factor: 4.180

10.  Activation of CD40 with platelet derived CD154 promotes reactive oxygen species dependent death of human hepatocytes during hypoxia and reoxygenation.

Authors:  Ricky H Bhogal; Christopher J Weston; Stuart M Curbishley; David H Adams; Simon C Afford
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.